Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Keywords » - entrée « Antibodies, Monoclonal, Humanized (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antibodies, Monoclonal, Humanized (administration & dosage) < Antibodies, Monoclonal, Humanized (adverse effects) < Antibodies, Monoclonal, Humanized (analysis)  Facettes :

List of bibliographic references indexed by Antibodies, Monoclonal, Humanized (adverse effects)

Number of relevant bibliographic references: 358.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000586 (2020) Tomohiro Koga ; Naoko Hagimori [Japon] ; Shuntaro Sato [Japon] ; Shinpei Morimoto [Japon] ; Naoki Hosogaya [Japon] ; Chizu Fukushima [Japon] ; Hiroshi Yamamoto [Japon] ; Atsushi KawakamiAn open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance
000695 (2019) Michitaro Hayakawa [Japon] ; Keisuke Izumi [Japon] ; Misako Higashida-Konishi [Japon] ; Mari Ushikubo [Japon] ; Masako Tsukamoto [Japon] ; Kumiko Akiya [Japon] ; Kazuhiro Araki [Japon] ; Hisaji Oshima [Japon]Tocilizumab-induced psoriasis-like eruption resolved by shortening the dose interval in a patient with rheumatoid arthritis: a case-based review.
000704 (2019) Kentaro Chino [Japon] ; Tsuneo Kondo [Japon] ; Ryota Sakai [Japon] ; Shuntaro Saito [Japon] ; Yusuke Okada [Japon] ; Akiko Shibata [Japon] ; Takahiko Kurasawa [Japon] ; Ayumi Okuyama [Japon] ; Hirofumi Takei [Japon] ; Koichi Amano [Japon]Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single-center, open-label study.
000706 (2019) Martina Biggioggero [Oman] ; Chiara Crotti [Italie] ; Andrea Becciolini [Oman] ; Ennio Giulio Favalli [Oman]Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.
000709 (2019) M Nica Calder N-Goercke [Espagne] ; Javier Loricera [Espagne] ; Vicente Aldasoro [Espagne] ; Santos Casta Eda [Espagne] ; Ignacio Villa [Espagne] ; Alicia Humbría [Espagne] ; Clara Moriano [Espagne] ; Susana Romero-Yuste [Espagne] ; Javier Narváez [Espagne] ; Catalina G Mez-Arango [Espagne] ; Eva Pérez-Pampín [Espagne] ; Rafael Melero [Espagne] ; Elena Becerra-Fernández [Espagne] ; Marcelino Revenga [Espagne] ; Noelia Álvarez-Rivas [Espagne] ; Carles Galisteo [Espagne] ; Francisca Sivera [Espagne] ; Alejandro Olivé-Marqués [Espagne] ; María Álvarez Del Buergo [Espagne] ; Luisa Marena-Rojas [Espagne] ; Carlos Fernández-L Pez [Espagne] ; Francisco Navarro [Espagne] ; Enrique Raya [Espagne] ; Eva Galindez-Agirregoikoa [Espagne] ; Beatriz Arca [Espagne] ; Roser Solans-Laqué [Espagne] ; Arantxa Conesa [Espagne] ; Cristina Hidalgo [Espagne] ; Carlos Vázquez [Espagne] ; José Andrés Román-Ivorra [Espagne] ; Pau Lluch [Espagne] ; Sara Manrique-Arija [Espagne] ; Paloma Vela [Espagne] ; Eugenio De Miguel [Espagne] ; Carmen Torres-Martín [Espagne] ; Juan Carlos Nieto [Espagne] ; Carmen Ordas-Calvo [Espagne] ; Eva Salgado-Pérez [Espagne] ; Cristina Luna-Gomez [Espagne] ; F Javier Toyos-Sáenz De Miera [Espagne] ; Nagore Fernández-Llanio [Espagne] ; Antonio García [Espagne] ; Carmen Larena [Espagne] ; Natalia Palmou-Fontana [Espagne] ; Vanesa Calvo-Río [Espagne] ; Diana Prieto-Pe A [Espagne] ; Carmen González-Vela [Espagne] ; Alfonso Corrales [Espagne] ; María Varela-García [Espagne] ; Elena Aurrecoechea [Espagne] ; Raquel Dos Santos [Espagne] ; Ángel García-Manzanares [Espagne] ; Norberto Ortego [Espagne] ; Sabela Fernández [Espagne] ; Francisco Ortiz-Sanjuán [Espagne] ; Montserrat Corteguera [Espagne] ; José L. Hernández [Espagne] ; Miguel González-Gay [Espagne] ; Ricardo Blanco [Espagne]Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.
000721 (2019) Jumpei Saito ; Naho Yakuwa ; Kayoko Kaneko [Japon] ; Chinatsu Takai ; Mikako Goto ; Ken Nakajima ; Akimasa Yamatani ; Atsuko MurashimaTocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum.
000723 (2019) Fenglong Xie [Royaume-Uni] ; Huifeng Yun [Royaume-Uni] ; Emily B. Levitan [Royaume-Uni] ; Paul Muntner [Royaume-Uni] ; Jeffrey R. Curtis [Royaume-Uni]Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients.
000728 (2019) Liyang Gu [Oman] ; Shuang YeTocilizumab Cannot Prevent the Development of Bronchiolitis Obliterans in Patients With Castleman Disease-Associated Paraneoplastic Pemphigus.
000818 (2019) C. Turesson [Suède] ; O. Börjesson [Suède] ; K. Larsson [Suède] ; A J Mohammad [Suède] ; A. Knight [Suède]Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis.
000865 (2019) Natalia Cabrera [France] ; Jean-Christophe Lega [France] ; Behrouz Kassai [France] ; Carine Wouters [Belgique] ; Anuela Kondi [France] ; Elvira Cannizzaro [Suisse] ; Andreas Woerner [Suisse] ; Aurelie Chausset [France] ; Samuel Roethlisberger [Suisse] ; Cyril Jeanneret [Suisse] ; Florence Aeschlimann [Suisse] ; Salma Malik [France] ; Agnès Duquesne [France] ; Daniela Kaiser [Suisse] ; Laetitia Higel [France] ; Anne Maes [Belgique] ; Gerald Berthet [Suisse] ; Veronique Hentgen [France] ; Isabelle Kone-Paut [France] ; Alexandre Belot [France] ; Michael Hofer [Suisse]Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database.
000870 (2019) Ching-Tsai Lin [Taïwan] ; Wen-Nan Huang [Taïwan] ; Chia-Wei Hsieh [Taïwan] ; Yi-Ming Chen [Taïwan] ; Der-Yuan Chen [Taïwan] ; Tsu-Yi Hsieh [Taïwan] ; Yi-Hsing Chen [Taïwan]Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis - A three-year study in Taiwan.
000880 (2019) Ajinkya Pawar [États-Unis] ; Rishi J. Desai [États-Unis] ; Daniel H. Solomon [États-Unis] ; Adrian J. Santiago Ortiz [États-Unis] ; Sara Gale [États-Unis] ; Min Bao [États-Unis] ; Khaled Sarsour [États-Unis] ; Sebastian Schneeweiss [États-Unis] ; Seoyoung C. Kim [États-Unis]Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.
000881 (2019) Kathrine Lederballe Gr N [Oman] ; Elizabeth V. Arkema [Suède] ; Bente Glintborg [Danemark] ; Frank Mehnert [Danemark] ; Mikkel Stergaard [Danemark] ; Lene Dreyer [Danemark] ; Mette N Rgaard [Danemark] ; Niels Steen Krogh [Danemark] ; Johan Askling [Suède] ; Merete Lund Hetland [Danemark]Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden.
000889 (2019) Ryuhei Yasuoka [Japon] ; Naomi Iwata [Japon] ; Naoki Abe [Japon] ; Toaki Kohagura [Japon] ; Haruna Nakaseko [Japon] ; Masaki Shimizu [Japon] ; Shinji Kawabe [Japon]Risk factors for hypersensitivity reactions to tocilizumab introduction in systemic juvenile idiopathic arthritis.
000902 (2019) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Yasuyo Abe [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Kiyoshi Aoyagi [Japon] ; Yukitaka Ueki [Japon]Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study.
000944 (2019) Cameron J. Williams [Australie] ; Andrew Foote [Australie] ; Philip Choi [Australie]Pseudomonas meningoencephalitis masquerading as a stroke in a patient on tocilizumab.
000955 (2019) Tomo Nozawa [Japon] ; Kenichi Nishimura [Japon] ; Asami Ohara [Japon] ; Ryoki Hara [Japon] ; Shuichi Ito [Japon]Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy.
000958 (2019) K. Brazdilova ; T. Koller ; Z. Killinger ; J. PayerPrevalence and risk factors for drug-induced liver injury among patients with rheumatic diseases treated with biological therapy: a single-center experience.
000988 (2019) María Ngeles González-Fernández [Espagne] ; Elena Villama N [Espagne] ; Inmaculada Jiménez-Nácher [Espagne] ; Francisco Moreno [Espagne] ; Alicia Herrero [Espagne] ; Alejandro Balsa [Espagne]Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients.
000A01 (2019) Hajime Yoshifuji [Japon]Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy.
000A54 (2019) Moshe C. Ornstein [États-Unis] ; Cassandra Calabrese [États-Unis] ; Laura S. Wood [États-Unis] ; Elizabeth Kirchner [États-Unis] ; Pamela Profusek [États-Unis] ; Kimberly D. Allman [États-Unis] ; Allison Martin [États-Unis] ; Apostolos Kontzias [États-Unis] ; Petros Grivas [États-Unis] ; Jorge A. Garcia [États-Unis] ; Leonard H. Calabrese [États-Unis] ; Brian I. Rini [États-Unis]Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antibodies, Monoclonal, Humanized (adverse effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antibodies, Monoclonal, Humanized (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antibodies, Monoclonal, Humanized (adverse effects)
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021